TITLE

HT associated with a decreased risk for breast cancer in BRCA1 mutations

PUB. DATE
October 2008
SOURCE
Hem/Onc Today;10/25/2008, Vol. 9 Issue 19, p35
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses results of a matched, case-controlled study on hormone therapy and breast cancer. According to a study conducted by researchers at the National Hospital in Oslo, Norway, published in a 2008 issue of the "Journal of the National Cancer Institute," hormone therapy lowers the risk of women with a BRCA1 mutation for breast cancer. The hormone therapy includes estrogen.
ACCESSION #
34781568

 

Related Articles

  • Risk of breast cancer and combined hormone therapy.  // Reactions Weekly;2/14/2009, Issue 1239, p3 

    The article discusses research being done on the association between the risk of breast cancer and conjugated estrogens/medroxyprogesterone. It references a study by R. T. Chlebowski and others published in the February 5, 2009 issue of "New England Journal of Medicine." The study concluded that...

  • The Effect of Prior Use of Hormone Therapy on Breast Cancer Survival. Speroff, Leon // OB/GYN Clinical Alert;Oct2008, Vol. 25 Issue 6, p41 

    The author reflects on the study concerning the effect of prior use of hormone therapy on breast cancer. He found the study's data striking which supports the argument that estrogen and progestin may not be more harmful, but beneficial. It favors the effect of hormone therapy on pre-existing...

  • Estrogen Receptor Status in Relation to Risk of Contralateral Breast Cancer--A Population-Based Cohort Study. Sandberg, Maria E. C.; Hall, Per; Hartman, Mikael; Johansson, Anna L. V.; Eloranta, Sandra; Ploner, Alexander; Czene, Kamila // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Background: It is unclear whether estrogen receptor (ER)-status of first primary breast cancer is associated with risk of metachronous (non-simultaneous) contralateral breast cancer (CBC), and to what extent endocrine therapy affects this association. Methods: We studied the effect of ER-status...

  • Diethylstilbestrol and Risk of Fatal Breast Cancer in a Prospective Cohort of US Women. Calle, Eugenia E.; Mervis, Cynthia A.; Thun, Michael J.; Rodriguez, Carmen; Wingo, Phyllis A.; Heath, Clark W. // American Journal of Epidemiology;1996, Vol. 144 Issue 7, p645 

    The authors examined the association between the use of diethylstilbestrol during pregnancy and the risk of subsequent fatal breast cancer in a large prospective study of US adults. After 9 years of follow-up, 1,574 cases of fatal breast cancer were observed among 501,536 gravid women who...

  • Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer? Westover, Kenneth D.; Westover, M. Brandon; Winer, Eric P.; Richardson, Andrea L.; Iglehart, J. Dirk; Punglia, Rinaa S. // International Journal of Breast Cancer;2011, p1 

    A negative sentinel lymph node (SLN) biopsy spares many breast cancer patients the complications associated with lymph node irradiation or additional surgery. However, patients at high risk for nodal involvement based on clinical characteristicsmay remain at unacceptably high risk of axillary...

  • Estrogen Alone Is Effective for Reducing Breast Cancer Risk, Study Finds.  // International Journal of Cancer Research;2011, Vol. 7 Issue 1, p77 

    No abstract available.

  • Combo hormone therapy has increased breast cancer risk over estrogen alone.  // Biomedical Market Newsletter;11/21/2011, Vol. 21, p279 

    The article reports on the result of research regarding the role of combo hormone therapy in increasing the risk for breast cancer over estrogen alone. According to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center, women taking the combination estrogen and progestin...

  • RELATIONSHIP BETWEEN FAMILY HISTORY OF BREAST CANCER AND CLINICOPATHOLOGICAL FEATURES IN MOROCCAN PATIENTS. Tazzite, Amal; Jouhadi, Hassan; Saiss, Kamal; Benider, Abdellatif; Nadifi, Sellama // Ethiopian Journal of Health Sciences;Jul2013, Vol. 23 Issue 2, p150 

    BACKGROUND: Breast cancer is the most common cancer affecting women all over the world. In addition to hormonal and environmental causes, family history is emerging as an important risk factor in the etiology of this disease. The aim of the present study is thus to compare the...

  • CITATIONS AND CLINICIANS' NOTES: BIOLOGY - RISK FACTORS.  // Current Medical Literature: Breast Cancer;2004, Vol. 16 Issue 3, p59 

    Presents several studies on the risk factors involved in breast cancer. "Increased Risk Factors of Breast Cancer Following Different Regimens of Hormone Replacement Therapy Frequently Used in Europe," by C. Stahlberg, A. T. Pedersen, E. Lynge, et al.; "Bilateral Prophylactic Mastectomy Reduces...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics